The world’s wealthiest individuals are significantly increasing their investments in life extension, making the longevity industry one of Silicon Valley’s hottest niches.
The industry is expected to reach a value of 578 billion euros by 2025, with the ultra-wealthy playing a leading role in its development. According to Swiss bank UBS, individuals with fortunes starting from 48 million euros are willing to spend up to half of their wealth in exchange for an additional 10 years of life.
One notable figure is 47-year-old entrepreneur and biohacker Bryan Johnson, who takes more than 50 pills daily, receives plasma from his young son, constantly monitors his heart rate and brain activity, and maintains a team of 30 specialists to combat aging. This regimen costs him 1.9 million euros annually.
Amazon founder Jeff Bezos has invested 2.9 billion euros in the biotech company Altos Labs, which aims to reprogram cells to stop or even reverse the aging process. PayPal co-founder Peter Thiel has invested 6.5 million euros in the Methuselah Foundation, which also focuses on aging research. OpenAI CEO Sam Altman is backing Retro Biosciences, a similar project, and has been actively seeking new investors at the World Economic Forum in Davos.
Marc Bernegger, co-founder of Longevity Investors, unites billionaires, scientists, and entrepreneurs to drive the longevity industry forward. He stated, “I want to live as long as I am happy and healthy. From a scientific perspective, living 90-120 years is entirely possible.”
The future impact of these investments on humanity remains uncertain, as noted by BILD editorial, with the ultimate question being time and money.
